Jaundice: Difference between revisions
| (6 intermediate revisions by 2 users not shown) | |||
| Line 26: | Line 26: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Jaundice DDX}} | |||
==Evaluation== | ==Evaluation== | ||
[[File:Evaluation of Hyperbilirubinemia.png|thumb|Evaluation algorithm]] | [[File:Evaluation of Hyperbilirubinemia.png|thumb|Evaluation algorithm]] | ||
[[File:Ddx for jaundice by labs.gif|right| | [[File:Ddx for jaundice by labs.gif|right|550px|Lab test for jaundice]] | ||
*Urine pregnancy | *Urine pregnancy | ||
*CBC | *CBC | ||
| Line 114: | Line 46: | ||
*Lipase | *Lipase | ||
*[[Urinalysis]] | *[[Urinalysis]] | ||
*?[[RUQ ultrasound|US]] vs. CT | *?[[RUQ ultrasound|US]] vs. CT vs MRCP | ||
*?Retic count | *?Retic count | ||
*?Haptoglobin/LDH | *?Haptoglobin/LDH | ||
| Line 134: | Line 66: | ||
*Moderate elevations are seen in all hepatocellular disorders and cirrhosis | *Moderate elevations are seen in all hepatocellular disorders and cirrhosis | ||
*Hemolysis results in elevation of LDH and unconjugated bili | *Hemolysis results in elevation of LDH and unconjugated bili | ||
====Ammonia==== | ====[[hyperammonemia|Ammonia]]==== | ||
*Elevation does NOT correlate with acute worsening of hepatic function in cirrhotic patient | *Elevation does NOT correlate with acute worsening of hepatic function in cirrhotic patient | ||
*Serves as marker of generalized decline than as diagnostic tool or therapeutic end point | *Serves as marker of generalized decline than as diagnostic tool or therapeutic end point | ||
Latest revision as of 05:59, 20 August 2022
For neonatal jaundice please see the Neonatal jaundice page
Background
- Bilirubin is end product of heme metabolism
- All bilirubin products in the body are initially unconjugated and is transported bound to albumin into hepatocytes t o becombined with glucuronic acid into conjugated bilirubin
- Conjugated bilirubin is then excreted into biliary tract
- Only conjugated bilirubin is water-soluble (present in urine)
- Normal bilirubin level is <1.1 (70% unconjugated)
Jaundice Types
Prehepatic (overproduction):
- Hemolysis
- Primarily unconjugated bili
Hepatic (inadequate processing):
Posthepatic (underexcretion):
- Pancreatic tumor, choledocholithiasis
- Primarily conjugated bili
Clinical Features
- Yellow skin, sclera
- +/- dark urine
Differential Diagnosis
Jaundice
Indirect Hyperbilirubinemia
- Hemolytic
- G6PD
- Drug related
- Autoimmune hemolytic anemia
- Hematoma resorption
- Ineffective erythropoiesis
- Gilbert's
Direct (Conjugated) Hyperbilirubinemia
- Choledocholithiasis
- Cholecystitis
- Ascending cholangitis
- AIDS cholangiopathy
- Stricture
- Neoplasm
- Pancreatic head
- Gallbladder
- Primary liver (e.g. hepatocellular carcinoma)
- Metastatic
- Obstructing AAA
Hepatocellular damage
Patient will have severely elevated AST/ALT with often normal Alkaline Phosphatase
- Viral hepatitis
- Fulminant hepatic failure
- alcoholic hepatitis
- Ischemic hepatitis
- Toxins
- Isoniazid
- Phenytoin
- acetaminophen
- Ritonavir
- Halothane
- Sulfonamide
- Autoimmune hepatitis
- Primary biliary cirrhosis
- HELLP Syndrome
- Congestive Hepatopathy
Pregnancy Related
Transplant Related
Pediatric Related
- Inborn error of metabolism
- Neonatal jaundice (physiologic)
Additional Differential Diagnosis
- Reye syndrome
- TPN
- Heatstroke
- Budd-Chiari (with acute ascites)
- Wilson's disease
- Sarcoidosis
- Amyloidosis
Masqueraders
Only bilirubin stains the sclera
- Carotenemia
- Quinacrine ingestion
- Dinitrophenol, teryl (explosive chemicals)
Evaluation
- Urine pregnancy
- CBC
- Chemistry
- LFTs
- Hepatocyte injury: AST, ALT, alk phos
- Hepatocyte catabolic activity: Bilirubin
- Coags
- Hepatocyte synthetic function
- Albumin
- Hepatocyte synthetic function
- Ammonia
- Hepatocyte catabolic activity
- Acute hepatitis panel
- Lipase
- Urinalysis
- ?US vs. CT vs MRCP
- ?Retic count
- ?Haptoglobin/LDH
- ?APAP/ASA/Utox/ETOH
Liver function tests
Transaminases
- Transaminases in hundreds associated with mild injury; thousands suggests extensive injury
- Elevations <5x normal typical of alcoholic liver disease
- AST:ALT ratio > 2 common in acute alcoholic hepatitis (alcohol stimulates AST production)
- May be normal in end-stage liver failure
- ALT more specific marker of hepatocyte injury than AST
Alk phos
- Mild to moderate elevations accompany virtually all hepatobiliary disease
- Elevations > 4x normal suggest cholestasis
GGT
- Elevation in setting of hepatitis suggestive of alcoholic etiology
LDH
- Moderate elevations are seen in all hepatocellular disorders and cirrhosis
- Hemolysis results in elevation of LDH and unconjugated bili
Ammonia
- Elevation does NOT correlate with acute worsening of hepatic function in cirrhotic patient
- Serves as marker of generalized decline than as diagnostic tool or therapeutic end point
Coagulation Markers (PT/PTT/INR)
- Marker of synthetic function
- Correlation between PT prolongation and clinical outcome in fulminant liver disease
Albumin
- Marker of synthetic function
- Half-life is 3 weeks so less useful than PT in evaluating fulminant liver disease
- Low levels also seen in malnutrition
Management
- Management is dependent on the diagnosis of either conjugated or unconjugated hyperblirubinemia and the severity of the elevation
Disposition
New Onset Jaundice Admission Criteria
- Transaminase >1,000 IU/L
- Tbil >10mg/dL
- Evidence coagulopathy